ArticleCancers2026

HSP90AA1 Knockdown Enhances Doxorubicin Sensitivity by Promoting Immunogenic Cell Death-Related Signaling and Immune-Related Tumor Microenvironment Remodeling in Breast Cancer.

Rui Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.